Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)

Sorafenib is the only standard treatment for unresectable hepatocellular carcinoma (HCC), but it provides modest survival benefits over placebo, necessitating predictive biomarkers of the response to sorafenib. Serum samples were obtained from 115 consecutive patients with HCC before sorafenib treat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Cell Proteomics
Hlavní autoři: Kim, Hyunsoo, Yu, Su Jong, Yeo, Injun, Cho, Young Youn, Lee, Dong Hyeon, Cho, Yuri, Cho, Eun Ju, Lee, Jeong-Hoon, Kim, Yoon Jun, Lee, Sungyoung, Jun, Jongsoo, Park, Taesung, Yoon, Jung-Hwan, Kim, Youngsoo
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society for Biochemistry and Molecular Biology 2017
Témata:
Technological Innovation and Resources
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500763/
https://ncbi.nlm.nih.gov/pubmed/28550167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M116.066704
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky